CSE CALI  |  Last $0.32  |  Change -0.01 OTC FNNZF  |  Last $0.25  |  Change -0.01

Our Mission is to combine extensive investment expertise, and industry experience in funding best-in-class businesses in the U.S. licensed medical cannabis industry with a focus on California.

The Company’s vision is to be the capital partner of choice for high growth, best-in-class businesses focused on the licensed U.S. medical cannabis industry

Why Are We Focused on Licensed Medical Cannabis?

Medical cannabis is becoming legalized rapidly on a global scale, which in turn has driven research initiatives to further discover medicinal benefits. With around 120 trials underway in Israel, the role of medical cannabis is sure to expand as cures and treatments are discovered and proven. [1]

FinCanna is focused on this sector and is confident that its investors and portfolio companies will benefit from this focus.

According to Arcview Market Research and partner BDS Analytics, worldwide spending on legal cannabis is expected to hit $57 billion by 2027. North America will continue to be the leader in legal cannabis buyers, as the $9.2 billion spent in 2017 is expected to grow to $47.3 billion by 2027. [2]

Research at the University of Georgia has found a link between medical cannabis and the decrease in opioid prescriptions in the states that permit dispensaries. The findings show from 2010 to 2015,  prescriptions filled for all opioids decreased by 2.11 million. [3] As more cures and treatments are discovered and proven, the role of medical cannabis is sure to expand.

The U.S. Cannabis Industry and California

  • Recent legislation in California is predicted to have a significant positive impact on U.S. licensed cannabis sales. Tom Adams of BDS Analytics expects national cannabis sales to increase from $9 billion (2017) to $11 billion in 2018. By 2021, sales are expected to reach $21 billion, with California being the sales leader both by volume and revenue;[4]

  • The medical market is projected to grow at 11.8% CAGR through 2025, growing from $5.1 billion in 2017 to an estimated $12.5 billion in 2025[5];

  • California not only has the largest state economy in the U.S., and also fifth largest economy in the world. With legal cannabis sales totaling approximately $2.5 billion in 2017[4], California is recognized as a global leader of the marijuana market.


Sources:
[1]Reuters, 2017. https://www.reuters.com/article/us-israel-cannabis/israel-looks-to-leverage-tech-in-50-billion-medical-marijuana-market-idUSKBN16U1PZ

[2]Forbes, 2018. https://www.forbes.com/sites/thomaspellechia/2018/03/01/double-digit-billions-puts-north-america-in-the-worldwide-cannabis-market-lead/#40c1ce426510

[3]  University of Georgia, 2018 https://jamanetwork.com/journals/jamainternalmedicine/article-abstract/2676999?redirect=true
[4] CNN, 2018. http://money.cnn.com/2018/01/31/news/marijuana-state-of-the-union/index.html

[5] New Frontier Data, 2018. https://globenewswire.com/news-release/2018/04/20/1482418/0/en/New-Frontier-Data-Projects-U-S-Legal-Cannabis-Market-to-Grow-to-25-Billion-by-2025.html

Subscribe for Updates